期刊文献+

纤维细胞在纤维化疾病中的作用 被引量:2

下载PDF
导出
摘要 纤维化是组织损伤和炎症造成的一系列反应的最终结果。病理性纤维化会导致永久性瘢痕形成,并损害器官功能。纤维化可发生在多种器官或组织中,如肝脏、肾脏、肺脏、心脏、胰腺、眼球、皮肤、关节等,是许多疾病的发病基础。纤维细胞拥有成纤维细胞[Ⅰ型胶原蛋白(collagen typeⅠ,ColⅠ),纤维连接蛋白和波形蛋白的表达]和造血细胞[白细胞分化抗原45(cluster of differentiation 45,CD45),CD34,主要组织相容性复合体Ⅱ(major histocompatibility complex Ⅱ, MHC Ⅱ ) CD11b, Gr1,Ly6c,CD54,CD80,CD86,CC类趋化因子受体2(CC-chemokine receptor2,CCR2),CCR1,CCR7和CCRS]的双重特征,且能够分泌促进细胞外基质沉积的生长因子。
出处 《河北医科大学学报》 CAS 2016年第9期1105-1108,共4页 Journal of Hebei Medical University
基金 云南省应用基础研究面上项目(2014FB152) 云南省科技厅-昆明医科大学联合专项(2012FB088)
  • 相关文献

参考文献1

二级参考文献74

  • 1Massarrat S, Fallahazad V, Kamalian N. Clinical, biochemicaland imaging-verified regression of hepatitis B-induced cirrhosis.Liver Int 2004; 24: 105-109 [PMID: 15078473 DOI: 10.1111/j.1478-3231.2004.00895.x].
  • 2Ghany MG, Strader DB, Thomas DL, Seeff LB. Diagnosis,management, and treatment of hepatitis C: an update. Hepatology2009; 49: 1335-1374 [PMID: 19330875 DOI: 10.1002/hep.22759].
  • 3Castera L. Invasive and non-invasive methods for the assessmentof fibrosis and disease progression in chronic liver disease. BestPract Res Clin Gastroenterol 2011; 25: 291-303 [PMID: 21497746DOI: 10.1016/j.bpg.2011.02.003].
  • 4Ishak K, Baptista A, Bianchi L, Callea F, De Groote J, Gudat F,Denk H, Desmet V, Korb G, MacSween RN. Histological gradingand staging of chronic hepatitis. J Hepatol 1995; 22: 696-699[PMID: 7560864].
  • 5Maharaj B, Maharaj RJ, Leary WP, Cooppan RM, Naran AD,Pirie D, Pudifin DJ. Sampling variability and its influence on thediagnostic yield of percutaneous needle biopsy of the liver. Lancet1986; 1: 523-525 [PMID: 2869260].
  • 6Seeff LB, Everson GT, Morgan TR, Curto TM, Lee WM, GhanyMG, Shiffman ML, Fontana RJ, Di Bisceglie AM, BonkovskyHL, Dienstag JL. Complication rate of percutaneous liver biopsiesamong persons with advanced chronic liver disease in the HALT-Ctrial. Clin Gastroenterol Hepatol 2010; 8: 877-883 [PMID:20362695 DOI: 10.1016/j.cgh.2010.03.025].
  • 7Bravo AA, Sheth SG, Chopra S. Liver biopsy. N Engl J Med 2001;344: 495-500 [PMID: 11172192 DOI: 10.1056/nejm200102153440706].
  • 8Parkes J, Guha IN, Roderick P, Rosenberg W. Performance ofserum marker panels for liver fibrosis in chronic hepatitis C. JHepatol 2006; 44: 462-474 [PMID: 16427156 DOI: 10.1016/j.jhep.2005.10.019].
  • 9Grigorescu M. Noninvasive biochemical markers of liver fibrosis.J Gastrointestin Liver Dis 2006; 15: 149-159 [PMID: 16802010].
  • 10Zardi EM, Caturelli E. May sonography distinguish between liverfibrosis and liver steatosis- Dig Liver Dis 2007; 39: 790 [PMID:17604239 DOI: 10.1016/j.dld.2007.05.001].

共引文献8

同被引文献6

引证文献2

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部